Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2014
10/02/2014WO2014154025A1 Application of a flavonoid in pharmaceutical preparation
10/02/2014US20140296276 Sequestered antagonist formulations
10/02/2014US20140294935 Vaccine composition
10/02/2014US20140294842 Assays, Methods and Means
10/02/2014US20140294829 Anti-ngf antibodies for the treatment of various disorders
10/01/2014EP2784090A1 Compositions for the treatment of systemic onset juvenile idiopathic arthritis
10/01/2014EP2782567A1 Disubstituted beta-lactones as inhibitors of n-acylethanolamine acid amidase (naaa)
10/01/2014EP2782563A1 Phytocannabinoids for use in the treatment of intestinal inflammatory diseases
09/2014
09/30/2014US8846681 Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
09/30/2014US8846409 Methods of preparing cannabinoids from plant material
09/30/2014US8846092 Gum resin as a carrier for topical application of pharmacologically active agents
09/30/2014CA2664152C Serine hydrolase inhibitors
09/25/2014WO2014152725A1 S1p and/or atx modulating agents
09/25/2014WO2014152621A1 P2x7 modulators
09/25/2014WO2014152604A1 P2x7 modulators
09/25/2014WO2014152444A1 Histone deacetylase inhibitors
09/25/2014WO2014151620A1 5-thiazolecarboxamide dervatives and their use as btk inhibitors
09/25/2014WO2014151472A1 Sodium channel modulators for the treatment of pain
09/25/2014WO2014151380A1 1,2,6-substituted benzimidazoles as flap modulators
09/25/2014WO2014151367A1 1,2,5-substituted benzimidazoles as flap modulators
09/25/2014WO2014151258A1 Substituted pyridine derivatives useful as c-fms kinase inhibitors
09/25/2014WO2014151206A1 Agonists of guanylate cyclase and their uses
09/25/2014WO2014150571A1 Reducing proinflammatory response
09/25/2014WO2014148638A1 Aptamer to il-17 and use thereof
09/25/2014WO2014148574A1 Inhibition of production of il-2
09/25/2014WO2014148489A1 Cyclic peptide
09/25/2014WO2014148422A1 Licorice hydrolysis extraction composition
09/25/2014WO2014147610A1 Astaxanthin anti-inflammatory synergistic combinations
09/25/2014WO2014147214A1 Use of sedoheptulose for prevention or treatment of inflammation
09/25/2014WO2014147178A1 Hdac6 inhibitors and uses thereof
09/25/2014WO2014146491A1 Geminally substituted cyanoethylpyrazolo pyridones as janus kinase inhibitors
09/25/2014WO2014146345A1 Tonic wine for dispelling rheumatism
09/25/2014WO2014146246A1 Cycloalkyl nitrile pyrazolo pyridones as janus kinase inhibitors
09/25/2014US20140288266 Synthesis of Cyclosporin Analogs
09/25/2014US20140288161 Urocortin-iii and uses thereof
09/24/2014EP2781219A1 Use of sedoheptulose for prevention or treatment of inflammation
09/24/2014EP2781216A1 Chemokine receptor activity regulator
09/24/2014EP2780360A1 Compositions and methods for treating autoimmune and inflammatory disorders
09/24/2014EP2780336A1 Structural variants of mycolactones for use in modulating inflammation, immunity and pain
09/24/2014EP2780025A1 USE OF EXTRACTS FROM FILIPENDULA FOR THE TREATMENT AND PROPHYLAXIS OF CHRONIC PAIN CONDITIONS& xA;
09/23/2014US8841307 Method of using diketopiperazines and composition containing them
09/23/2014US8841254 Method for treatment of anxiety
09/18/2014WO2014145749A1 Targeted polymeric inflammation-resolving nanoparticles
09/18/2014WO2014145050A1 Histidyl-trna synthetase-fc conjugates
09/18/2014WO2014143768A1 Tricyclic heterocycles as bet protein inhibitors
09/18/2014WO2014143672A1 Macrocyclic compounds as irak4 inhibitors for the treatment of inflammatory diseases
09/18/2014WO2014143146A1 Methods of administering monomethyl fumarate
09/18/2014WO2014142255A1 Heterocyclic compound
09/18/2014WO2014142012A1 Ophthalmic composition for soft contact lens
09/18/2014WO2014140592A1 Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as ssao inhibitors
09/18/2014WO2014140591A1 New compounds
09/18/2014WO2014140582A1 Kinase inhibitors
09/18/2014WO2014140313A1 Macrocyclic salt-inducible kinase inhibitors
09/18/2014WO2014140299A1 Macrocyclic rip2 kinase inhibitors
09/18/2014WO2014140077A1 Furopyridines as bromodomain inhibitors
09/18/2014WO2014139978A1 New octahydro-pyrrolo[3,4-c]-pyrrole derivatives and analogs thereof as autotaxin inhibitors
09/18/2014WO2014139970A1 Processes and intermediates for preparing a medicament
09/18/2014WO2014139882A1 Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
09/18/2014WO2014138897A1 Hyaluronic acid derivatives
09/18/2014WO2014138862A1 Human monoclonal antibodies that neutralize bioactivity of granulocyte macrophage colony-stimulating factor and methods and uses thereof
09/18/2014US20140275618 Therapeutic compounds and methods of use
09/18/2014US20140275545 8-carboxamido-2,6-methano-3-benzazocines
09/18/2014US20140275115 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
09/18/2014US20140271637 Methods of administering anti-tnfalpha antibodies
09/17/2014EP2776467A1 Methods of treating inflammatory disorders using anti-m-csf antibodies
09/17/2014EP2776445A1 Therapeutically active thiazolo-pyrimidine derivatives
09/17/2014EP2776437A1 Modulators of opioid receptors and methods of use thereof
09/17/2014EP2776424A1 Substituted pyrazolyl-based carboxamide and urea derivatives bearing a phenyl moiety substituted with an n-cyclic group as vanilloid receptor ligands
09/17/2014EP2776403A1 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (fprl-1) receptor modulators
09/17/2014EP2776401A1 Substituted pyrazolyl-based carboxamide and urea derivatives bearing a phenyl moiety substituted with an so2-containing group as vanilloid receptor ligands
09/17/2014EP2776400A1 Substituted pyrazolyl-based carboxamide and urea derivatives bearing a phenyl moiety substituted with a co-containing group as vanilloid receptor ligands
09/17/2014EP2776399A1 Substituted pyrazolyl-based carboxamide and urea derivatives bearing a phenyl moiety substituted with an n-containing group as vanilloid receptor ligands
09/17/2014EP2776398A1 Substituted pyrazolyl-based carboxamide and urea derivatives bearing a phenyl moiety substituted with an o-containing group as vanilloid receptor ligands
09/17/2014EP2776393A1 Nampt inhibitors
09/17/2014EP2776046A1 Compositions, dosage forms, and coadministration of an opioid agonist compound and an analgesic compound
09/17/2014EP2776036A1 Methods for treating inflammatory diseases and pharmaceutical combinations useful therefor
09/16/2014US8835435 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
09/16/2014US8835434 Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
09/16/2014US8835430 2,4-pyrimidinediamine compounds and their uses
09/16/2014US8835389 Use of calcitonin for the treatment of RA
09/16/2014US8834897 Methods for using tetanus toxin for beneficial purposes in animals (mammals)
09/16/2014CA2650970C P38 map kinase inhibitors
09/16/2014CA2454644C Cannabinoid liquid formulations for mucosal administration
09/12/2014WO2014138437A1 Steroid conjugates
09/12/2014WO2014138375A1 Antibiotic conjugates linked with steroid drugs
09/12/2014WO2014138359A1 Steroid antibiotic conjugates
09/12/2014WO2014138350A1 Antibiotic conjugates directly linked with steroid drugs
09/12/2014WO2014138343A1 Antibiotic conjugates with nonsteroidal anti-inflammatory drugs
09/12/2014WO2014137211A1 Use of faecali bacterium prausnitzii htf-f (dsm 26943) to suppress inflammation.
09/12/2014WO2014136932A1 Anti-inflammatory agent
09/12/2014WO2014136910A1 ANTIBODY TO PEPTIDE ENCODED BY Exon-21 OF PERIOSTIN, AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF INFLAMMATORY DISEASE CONTAINING SAID ANTIBODY
09/12/2014WO2014136717A1 Transdermally absorbable pharmaceutical composition
09/12/2014WO2014136116A1 Lipid conjugates in the treatment of bronchitis
09/12/2014WO2014135955A1 Pyrimidine carboxamides as sodium channel blockers
09/12/2014WO2014135776A1 Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same
09/12/2014WO2014135617A1 Novel sulfonamide trpa1 receptor antagonists
09/12/2014WO2014135529A1 Mixture of fatty acids for use in the treatment of inflammatory pathologies
09/12/2014WO2014134968A1 Pyrrolidonopyrazole compounds and use thereof as drugs
09/12/2014WO2014134922A1 Meloxicam eye drops and preparation method and use thereof
09/11/2014US20140256743 Cathepsin cysteine protease inhibitors
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 1272